Psoriasis Treatment Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Is Expected To Reach US$<br />
12.8 Bn By 2025 – Credence Research<br />
According to the latest market report published by Credence Research, Inc. “<strong>Psoriasis</strong> <strong>Treatment</strong><br />
<strong>Market</strong> – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global <strong>Psoriasis</strong><br />
<strong>Treatment</strong> market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by<br />
2025, expanding at a CAGR of 5.4% from 2017 to 2025.<br />
Browse the full report <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> – Growth, Future Prospects and<br />
Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/psoriasistreatment-market<br />
<strong>Market</strong> Insights<br />
<strong>Psoriasis</strong> is a chronic, inflammatory, painful skin disease for which there is no cure with great<br />
negative impact on patient’s quality of life. Primary goal of treatment is to reduce inflammation<br />
and to stop the skin cells from growing quickly. <strong>Psoriasis</strong> treatment market is rapidly growing due<br />
to factors such as growing prevalence in some countries, significant unmet needs, promising<br />
pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of<br />
study, global psoriasis treatment market is segmented on the basis of drug class such as TNF<br />
Inhibitors, Vitamin D analogues, interleukin blockers and other psoriasis medication. It is observed<br />
that, in the base year 2016, interleukin blockers was major revenue contributing segment due to its<br />
long-term safety with lower risk of infection and malignancy. <strong>Psoriasis</strong> treatment market is<br />
categorized on the basis of route of administration such as topical, oral and parenteral therapeutic<br />
drugs. Currently, topical therapeutic drugs hold largest market share due to its safety, more<br />
effectiveness and targeted drug delivery. It is anticipated that parenteral therapeutic drugs would<br />
show significant growth during forecast period because newly approved biologics are generally<br />
preferred in moderate to severe psoriasis. <strong>Psoriasis</strong> treatment market is currently dominated by<br />
North America, factors such as higher cost of therapy, higher number of psoriasis patient,<br />
government reimbursement policies fueling the growth of psoriasis treatment market in North<br />
America.<br />
Request Free Sample of This Report @ http://www.credenceresearch.com/samplerequest/58469
<strong>Market</strong> Competition Assessment:<br />
The psoriasis treatment market is observed to be highly competitive and comprises large number<br />
of players. However, the market is currently dominated by few players such as AbbVie Inc.,<br />
Amgen Inc., AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly and Company,<br />
Johnson & Johnson, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Stiefel<br />
Laboratories Inc. (GlaxoSmithKline plc.), Sun Pharmaceutical Industries and other.<br />
Key <strong>Market</strong> Movements:<br />
<br />
<br />
<br />
Factors such as higher prevalence psoriasis disease, increasing treatment awareness, higher<br />
treatment compliance and favorable reimbursement policies in some countries are driving<br />
the market growth of psoriasis treatment worldwide.<br />
Due to the high unmet needs, vendors in the market are focusing in development of ideal<br />
treatment, promising pipeline molecule, rising access for the treatment medication in some<br />
developing countries, increase in incidence of psoriasis and skin disorders would fuel the<br />
growth of psoriasis treatment market during forecast period.<br />
However, patent expiry of blockbuster drugs leads to generic erosion and adverse effects<br />
associated with the use of medication which would negatively impact the growth of<br />
psoriasis treatment market.<br />
Request Free Sample of This Report @ http://www.credenceresearch.com/samplerequest/58469
Table of Content<br />
Chapter 1 Preface<br />
1.1 Report Description<br />
1.1.1 Purpose of the Report<br />
1.1.2 Target Audience<br />
1.1.3 USP and Key Offerings<br />
1.2 Research Scope<br />
1.3 Research Methodology<br />
1.3.1 Phase I – Secondary Research<br />
1.3.2 Phase II – Primary Research<br />
1.3.3 Phase III – Expert Panel Review<br />
1.3.4 Assumptions<br />
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />
Chapter 2 Executive Summary<br />
2.1 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Snapshot<br />
2.2 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, Drug Class<br />
2.3 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, Type<br />
2.4 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Share, by Geography, 2016 (Value %)<br />
Chapter 3 <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Analysis<br />
3.1 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Overview<br />
3.2 <strong>Market</strong> Dynamics<br />
3.2.1 <strong>Market</strong> Drivers<br />
3.2.2 Challenges<br />
3.2.3 Opportunities<br />
3.3 Pipeline Analysis in <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>
3.4 Global Epidemiology Data for <strong>Psoriasis</strong><br />
3.5 Comparative study of <strong>Psoriasis</strong> Therapeutics<br />
3.5.1 Tremfya (Guselkumab)<br />
3.5.2 Siliq (Brodalumab)<br />
3.5.3 Taltz (Ixekizumab)<br />
3.6 Attractive Investment Proposition<br />
3.7 Competitive Landscape of Key Players in <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong><br />
Chapter 4 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class<br />
4.1 Overview<br />
4.2 Top 3 Countries<br />
4.3 TNF Inhibitors<br />
4.4 Vitamin D Analogues<br />
4.5 Interleukin Blockers<br />
4.6 Topical Corticosteroids<br />
4.7 Other<br />
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />
Chapter 5 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type<br />
5.1 Overview<br />
5.2 Top 3 Countries<br />
5.3 Plaque psoriasis<br />
5.4 Guttate psoriasis<br />
5.5 Flexural or inverse psoriasis<br />
5.6 Psoriatic arthritis<br />
5.7 Other
Chapter 6 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, By Geography<br />
6.1 Preface<br />
6.2 North America (U.S. & Canada)<br />
6.2.1 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />
6.2.2 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />
6.2.3 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />
6.3 Europe (U.K., Germany & Rest of Europe)<br />
6.3.1 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />
6.3.2 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />
6.3.3 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />
6.4 Asia Pacific (China, Japan and Rest of APAC)<br />
6.4.1 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />
6.4.2 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />
6.4.1 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />
6.5 Latin America (Brazil, Mexico and Rest of LATAM)<br />
6.5.1 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />
6.5.2 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />
6.5.3 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />
6.6 Middle East and Africa (GCC and Rest of MEA)<br />
6.6.1 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015- 2025 (US$)<br />
6.6.2 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015- 2025 (US$)<br />
6.6.3 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015- 2025 (US$)<br />
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />
Chapter 7 Company Profiles<br />
7.1 AbbVie Inc.<br />
7.2 Amgen Inc.
7.3 AstraZeneca<br />
7.4 Biogen<br />
7.5 Boehringer Ingelheim<br />
7.6 Celgene<br />
7.7 Eli Lilly and Company<br />
7.8 Johnson & Johnson<br />
7.9 LEO Pharma A/S<br />
7.10 Merck & Co., Inc.<br />
7.11 Novartis AG<br />
7.12 Pfizer, Inc.<br />
7.13 Stiefel Laboratories Inc. (GlaxoSmithKline plc)<br />
7.14 Sun Pharmaceutical Industries<br />
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />
List Of Table<br />
TABLE 1 <strong>Market</strong> Positioning of Key Players in Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong><br />
TABLE 2 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015 – 2025 (US$ Bn)<br />
TABLE 3 Top 3 Countries in Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
TABLE 4 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015 – 2025 (US$ Bn)<br />
TABLE 5 Top 3 Countries in Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
TABLE 6 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Geography, 2015 – 2025 (US$ Bn)<br />
TABLE 7 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />
TABLE 8 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />
TABLE 9 North America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)<br />
TABLE 10 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />
TABLE 11 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />
TABLE 12 Europe <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />
TABLE 14 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />
TABLE 15 Asia Pacific <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)<br />
TABLE 16 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />
TABLE 17 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />
TABLE 18 Latin America <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)<br />
TABLE 19 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2015-2025 (US$ Bn)<br />
TABLE 20 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2015-2025 (US$ Bn)<br />
TABLE 21 Middle East and Africa <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Country, 2015 – 2025 (US$ Bn)<br />
TABLE 22 AbbVie Inc.: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 23 Amgen Inc.: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 24 AstraZeneca: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 25 Biogen: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 26 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 27 Celgene: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />
TABLE 28 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 29 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 30 LEO Pharma A/S: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 31 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)
TABLE 32 Novartis AG: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 33 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product<br />
Position/Portfolio; News Coverage)<br />
TABLE 34 Stiefel Laboratories Inc. (GlaxoSmithKline plc): Company Snapshot (Business Description;<br />
Financial Information; Product Position/Portfolio; News Coverage)<br />
TABLE 35 Sun Pharmaceutical Industries: Company Snapshot (Business Description; Financial Information;<br />
Product Position/Portfolio; News Coverage)<br />
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market<br />
List Of Figures<br />
FIG. 1 <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>: Research Methodology<br />
FIG. 2 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Drug Class, 2016 (US$ Bn)<br />
FIG. 3 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Type, 2016 (US$ Bn)<br />
FIG. 4 Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong> Share, by Geography, 2016 (Value %)<br />
FIG. 5 Attractive Investment Proposition: Global <strong>Psoriasis</strong> <strong>Treatment</strong> <strong>Market</strong>, by Geography, 2016<br />
FIG. 6 Global TNF Inhibitors <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
FIG. 7 Global Vitamin D Analogues <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
FIG. 8 Global Interleukin Blockers <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
FIG. 9 Global Topical Corticosteroids <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
FIG. 10 Global Other <strong>Psoriasis</strong> Medication <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
FIG. 11 Global Plaque <strong>Psoriasis</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
FIG. 12 Global Guttate <strong>Psoriasis</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
FIG. 13 Global Flexural or Inverse <strong>Psoriasis</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
FIG. 14 Global Psoriatic Arthritis <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
FIG. 15 Global Other Types of <strong>Psoriasis</strong> <strong>Market</strong>, 2015 – 2025 (US$ Bn)<br />
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market
About Credence Research:<br />
Credence Research is a worldwide market research and counseling firm that serves driving organizations,<br />
governments, non legislative associations, and not-for-benefits. We offer our customers some assistance<br />
with making enduring enhancements to their execution and understand their most imperative objectives.<br />
Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.<br />
For More Information, Visit: http://www.credenceresearch.com/<br />
Media Contact<br />
Company Name: Credence Research<br />
Contact Person: Chris Smith,<br />
Designation: Global Sales Manager<br />
Phone: +1-800-361-8290 FREE<br />
Address: 105 N 1st ST #429, SAN JOSE,<br />
CA 95103<br />
E-mail: sales@credenceresearch.com